Explore tweets tagged as #CSCR
#BioE3Pakhwada. India’s first in-human gene therapy trial for Hemophilia A was successfully completed in 2024 by @DBT_inStem and @CSCR_CMC_inStem, Vellore. Using a lentiviral vector instead of AAV, this advanced therapy achieved sustained Factor VIII expression, eliminating
1
7
20
Low IOP, High OPP Risk Factors for CSCR. Choroidal overperfusion and exudation that reduces the interstitial fluid clearance across the sclera could be part of the disease’s pathogenesis. #retina #optometry
3
6
23